155 related articles for article (PubMed ID: 34488924)
21. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.
Ivanov VN; Zhou H; Partridge MA; Hei TK
Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839
[TBL] [Abstract][Full Text] [Related]
22. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.
Liu Y; Hawkins OE; Vilgelm AE; Pawlikowski JS; Ecsedy JA; Sosman JA; Kelley MC; Richmond A
Clin Cancer Res; 2015 Dec; 21(23):5338-48. PubMed ID: 26152738
[TBL] [Abstract][Full Text] [Related]
23. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
[TBL] [Abstract][Full Text] [Related]
24. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.
Han X; Ren C; Lu C; Qiao P; Yang T; Yu Z
Cell Death Differ; 2022 Sep; 29(9):1864-1873. PubMed ID: 35296795
[TBL] [Abstract][Full Text] [Related]
25. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.
Tse AK; Cao HH; Cheng CY; Kwan HY; Yu H; Fong WF; Yu ZL
J Invest Dermatol; 2014 May; 134(5):1397-1407. PubMed ID: 24213373
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax.
Berger A; Quast SA; Plötz M; Kammermeier A; Eberle J
Cell Death Dis; 2013 Jan; 4(1):e477. PubMed ID: 23348591
[TBL] [Abstract][Full Text] [Related]
27. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
Sun J; Yu X; Wang C; Yu C; Li Z; Nie W; Xu X; Miao X; Jin X
Med Sci Monit; 2017 Mar; 23():1190-1199. PubMed ID: 28270653
[TBL] [Abstract][Full Text] [Related]
28. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
[TBL] [Abstract][Full Text] [Related]
29. Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Bai T; Tanaka T; Yukawa K
Int J Oncol; 2010 Jul; 37(1):203-10. PubMed ID: 20514412
[TBL] [Abstract][Full Text] [Related]
30. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
[TBL] [Abstract][Full Text] [Related]
31. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.
Jin Y; Qiu S; Shao N; Zheng J
Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370
[TBL] [Abstract][Full Text] [Related]
32. Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma.
Karasic TB; Hei TK; Ivanov VN
Exp Cell Res; 2010 Jul; 316(12):1994-2007. PubMed ID: 20417200
[TBL] [Abstract][Full Text] [Related]
33. The siRNA-mediated downregulation of N-Ras sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors.
Ahn JH; Lee M
Mol Cell Biochem; 2014 Jul; 392(1-2):239-47. PubMed ID: 24671490
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.
Johnson GE; Ivanov VN; Hei TK
Apoptosis; 2008 Jun; 13(6):790-802. PubMed ID: 18454317
[TBL] [Abstract][Full Text] [Related]
35. Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis.
Tolksdorf B; Zarif S; Eberle J; Hazini A; Dieringer B; Jönsson F; Kreppel F; Kurreck J; Fechner H
J Mol Med (Berl); 2021 Sep; 99(9):1279-1291. PubMed ID: 34028599
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
Hu Z; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
[TBL] [Abstract][Full Text] [Related]
37. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
38. Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells.
Yang F; Tay KH; Dong L; Thorne RF; Jiang CC; Yang E; Tseng HY; Liu H; Christopherson R; Hersey P; Zhang XD
Cell Death Differ; 2010 Aug; 17(8):1354-67. PubMed ID: 20300110
[TBL] [Abstract][Full Text] [Related]
39. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway.
Wang WQ; Zhang H; Wang HB; Sun YG; Peng ZH; Zhou G; Yang SM; Wang RQ; Fang DC
Mol Diagn Ther; 2010 Jun; 14(3):155-61. PubMed ID: 20560677
[TBL] [Abstract][Full Text] [Related]
40. TRAIL-induced apoptosis of human melanoma cells involves activation of caspase-4.
Mao ZG; Jiang CC; Yang F; Thorne RF; Hersey P; Zhang XD
Apoptosis; 2010 Oct; 15(10):1211-22. PubMed ID: 20514521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
